Authors: SORGEL F ZAIGLER M MEDERT G KINZIGSCHIPPERS M KOHLER H PATZELTBATH A RUSING G FUHR U STAIB AH

Citation: F. Sorgel et al., GLIBENCLAMIDE - AN EXAMPLE HOW APPARENT ELIMINATION HALF-LIFE AND BIOAVAILABILITY MAY DEPEND ON ASSAY SENSITIVITY, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 486-486